HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Gradl Selected Research

orludodstat

10/2019The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Gradl Research Topics

Disease

5Neoplasms (Cancer)
02/2021 - 10/2019
1Genetic Translocation (Chromosomal Translocation)
10/2019
1Acute Promyelocytic Leukemia
10/2019

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
02/2021 - 01/2021
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2021
1human ERBB2 proteinIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
01/2021
1Phospholipid Hydroperoxide Glutathione PeroxidaseIBA
01/2020
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2019
16- (4- (diethylamino)- 3- nitrophenyl)- 5- methyl- 4,5- dihydropyridazin- 3(2H)- oneIBA
11/2019
1Retinoic Acid Receptor alphaIBA
10/2019
1Dihydroorotate DehydrogenaseIBA
10/2019
1orludodstatIBA
10/2019

Therapy/Procedure

1Therapeutics
01/2020